Latham & Watkins advises Revolution Medicines on the deal, and Goodwin Procter advises EQRx. Revolution Medicines, Inc. (Nasdaq: RVMD) and EQRx, Inc. (Nasdaq: EQRX) announced a definitive agreement...
Revolution Medicines’ Acquisition of EQRx
Cadence’s Acquisition of Rambus PHY IP Assets
Latham & Watkins advised Cadence, and Wilson Sonsini Goodrich & Rosati advised Rambus on the transaction. Cadence Design Systems, Inc. and Rambus Inc. announced that they have entered...
dbt Labs’ Acquisition of Transform Data
Latham & Watkins advised dbt Labs on the deal. dbt Labs announced that it has signed a definitive agreement to acquire Transform Data Inc. The acquisition...